WENAW
Income statement / Annual
Last year (2022), Anew Medical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Anew Medical, Inc.'s net income was -$598,593.00.
See Anew Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
Period Ended |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
Research and Development Expenses |
$0.00
|
$0.00
|
General & Administrative Expenses |
$574,374.00
|
$1.11 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$574,374.00
|
$1.11 M
|
Other Expenses |
$147.00
|
$44.00
|
Operating Expenses |
$574,374.00
|
$1.11 M
|
Cost And Expenses |
$574,374.00
|
$1.11 M
|
Interest Income |
$0.00
|
$0.00
|
Interest Expense |
$24,366.00
|
$0.00
|
Depreciation & Amortization |
$147.00
|
$44.00
|
EBITDA |
-$574,227.00 |
-$1.11 M |
EBITDA Ratio |
0
|
0
|
Operating Income Ratio |
0
|
0
|
Total Other Income/Expenses Net |
-$24,219.00
|
$44.00
|
Income Before Tax |
-$598,593.00
|
-$1.11 M
|
Income Before Tax Ratio |
0
|
0
|
Income Tax Expense |
$24,366.00
|
$0.00
|
Net Income |
-$598,593.00
|
-$1.11 M
|
Net Income Ratio |
0
|
0
|
EPS |
-0.18 |
-0.34 |
EPS Diluted |
-0.18 |
-0.34 |
Weighted Average Shares Out |
$3.24 M
|
$3.24 M
|
Weighted Average Shares Out Diluted |
$3.24 M
|
$3.24 M
|
Link |
|
|